CTRI/2024/06/068676尚未招募2 期
A Phase II randomized controlled trial of Deuterium Depleted Water (DDW) administration or regular water in patients receiving neoadjuvant chemotherapy (NACT) for triple negative (TNBC) or HER2 positive breast cancer - NI
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All individuals above 18 years of age having histopathologicaly proven,
- •triple negative breast cancer (mTNBC) or Her-2 positive breast cancer who
- •are going to receive neo-adjuvant chemotherapy.
- •2. Has a performance status of 0-3 on the Eastern Cooperative Oncology
- •Group (ECOG) Performance Scale.
- •3. Willing and able to provide written informed consent and able to comply with
- •all trial procedures.
排除标准
- •1. Patients who do not have histopathologicaly proven triple negative breast
- •cancer (mTNBC) or Her-2 positive breast cancer
- •2. Patients who are not eligible for neo-adjuvant chemotherapy.
研究者
相似试验
招募中
1 期
Phase II Dutasteride in combination with CAB vs CAB in SDC (DUCT)Salivary Duct CarcinomaCTIS2022-500745-24-00Stichting Radboud University Medical Center26
已完成
2 期
A Randomised Phase II trial investigating the duration of adjuvant therapy(6 versus 12 months) with S-1 for patients after resection of pancreatic cancerResected pancreatic cancerJPRN-UMIN000012634Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University170
进行中（未招募）
1 期
A randomized placebo-controlled phase 2 study of decitabine with or without eltrombopag in patients with acute myeloid leukemia =65 years of age not eligible for intensive chemotherapyEUCTR2014-003150-13-DETechnische Universität Dresden238
未知
2 期
Phase 2 study of DS-8500aType 2 Diabetes MellitusJPRN-jRCT2080222546DAIICHISANKYO Co.,Ltd.90
进行中（未招募）
2 期
A randomized phase II study of FOLFOXIRI plus cetuximab versus FOLFOXIRI plus bevacizumab in metastatic colorectal cancer patients with RAS wild-type tumorscolorectal cancerJPRN-jRCTs061180022TSUJI Akihito360